Literature DB >> 30317203

Stage III Kienböck's disease treated with hyperbaric oxygen: the role of an unusual approach to a rare condition.

Paulo Jorge Figueira1,2, Diogo Alpuim Costa3,4, Nunzio Barbagallo5, Francisco Gamito Guerreiro4,6.   

Abstract

Kienböck's disease is a rare condition characterised by avascular necrosis of the lunate bone. Its natural history and aetiopathogenesis have not yet been clarified, nor are its triggering factors identified. We present a case of a 17-year-old male gymnast, without relevant medical/family history, with stage IIIA Kienböck's disease diagnosed in 2016. Initially, submitted to conservative treatment that proved to be insufficient. Consequently, surgical treatment was proposed, but refused. The patient instead underwent experimental treatment with hyperbaric oxygen (120 sessions, 100% oxygen at 2.5 atm, for 70 min periods, once daily, five times per week). In April 2018, a favourable clinical and radiological evolution was observed, with an improvement in the patterns of pain, motion and strength and an almost complete involution of the process of aseptic necrosis of the semilunar. To the best of our knowledge, this is the first report of Kienböck's disease treated with hyperbaric oxygen. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  drugs: musculoskeletal and joint diseases; medical management; musculoskeletal and joint disorders; orthopaedics; therapeutic indications

Mesh:

Year:  2018        PMID: 30317203      PMCID: PMC6194444          DOI: 10.1136/bcr-2018-226090

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

Review 1.  Ten questions on Kienbock's disease of the lunate.

Authors:  Joseph J Dias; Peter Lunn
Journal:  J Hand Surg Eur Vol       Date:  2010-05-24

2.  Avascular necrosis of lunate bone: Kienbock disease.

Authors:  Ömer Salt; Mustafa Burak Sayhan
Journal:  Am J Emerg Med       Date:  2015-11-18       Impact factor: 2.469

Review 3.  Kienböck Disease: Moving Forward.

Authors:  David M Lichtman; William F Pientka; Gregory I Bain
Journal:  J Hand Surg Am       Date:  2016-04-05       Impact factor: 2.230

4.  Vasculogenic stem cell mobilization and wound recruitment in diabetic patients: increased cell number and intracellular regulatory protein content associated with hyperbaric oxygen therapy.

Authors:  Stephen R Thom; Tatyana N Milovanova; Ming Yang; Veena M Bhopale; Elena M Sorokina; Günalp Uzun; D Scot Malay; Michael A Troiano; Kevin R Hardy; David S Lambert; Christopher J Logue; David J Margolis
Journal:  Wound Repair Regen       Date:  2011 Mar-Apr       Impact factor: 3.617

5.  Correction to Mathieu D, Marroni A, Kot J: Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving Hyperb Med. 2017 Mar;47(1):24-32.

Authors:  Daniel Mathieu; Alessandro Marroni; Jacek Kot
Journal:  Diving Hyperb Med       Date:  2017-06       Impact factor: 0.887

6.  Blood vessel transplantation to bone.

Authors:  Y Hori; S Tamai; H Okuda; H Sakamoto; T Takita; K Masuhara
Journal:  J Hand Surg Am       Date:  1979-01       Impact factor: 2.230

Review 7.  [Hyperbaric medicine].

Authors:  Tiago D F Fernandes
Journal:  Acta Med Port       Date:  2009-08-10

8.  Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo.

Authors:  Tatyana N Milovanova; Veena M Bhopale; Elena M Sorokina; Jonni S Moore; Thomas K Hunt; Martin Hauer-Jensen; Omaida C Velazquez; Stephen R Thom
Journal:  J Appl Physiol (1985)       Date:  2008-11-20

9.  CD34+/CD45-dim stem cell mobilization by hyperbaric oxygen - changes with oxygen dosage.

Authors:  Marvin Heyboer; Tatyana N Milovanova; Susan Wojcik; William Grant; Mary Chin; Kevin R Hardy; David S Lambert; Christopher Logue; Stephen R Thom
Journal:  Stem Cell Res       Date:  2014-02-28       Impact factor: 2.020

10.  A new treatment strategy for Kienböck's disease: combination of bone marrow transfusion, low-intensity pulsed ultrasound therapy, and external fixation.

Authors:  Takeshi Ogawa; Naoyuki Ochiai; Yasumasa Nishiura; Toshikazu Tanaka; Yuki Hara
Journal:  J Orthop Sci       Date:  2012-11-01       Impact factor: 1.601

View more
  1 in total

1.  Repetitive Microtrauma and Negative Ulnar Variance as Possible Culprits of Avascular Necrosis of the Lunate.

Authors:  Milad Heydari-Kamjani; Sadaf Afraz; Danay Herrera; Michelle Demory Beckler; Marc M Kesselman
Journal:  Cureus       Date:  2019-10-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.